Brief: Camurus Announces Approval Of Oczyesa For The Treatment Of Acromegaly In The UK
28/08/2025 16:47
Aug 28 (Reuters) - Camurus AB CAMX.ST: CAMURUS ANNOUNCES APPROVAL OF OCZYESA® FOR THE TREATMENT OF ACROMEGALY IN THE UK CAMURUS AB - TO LAUNCH OCZYESA IN UK IN Q4 2025 Source text: ID:nPre79S71a Further company coverage: CAMX.ST ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Camurus AB
See all newsBrief: Camurus Receives Approval In Canada For Oczyesa XR
Brief: Executive Sells About £279,000 Of Camurus Shares
Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk
Brief: Camurus Says NDA Resubmission For CAM2029 In Acromegaly Accepted For Review By FDA
Camurus shares rise after Q2 revenue, operating profit beat